marijuana stocks

ENDEXX Corp. (EDXC)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 35   –   –   –  
Cost of Revenue – – – –
Gross Profit 35   –   –   –  
Operating Expenses
Research Development 50 64 2 0
Selling General and Administrative 252 178 99 64
Non Recurring – – – –
Others 0 0 0 0
Total Operating Expenses – – – –
Operating Income or Loss (268) (243) (101) (65)
Income from Continuing Operations
Total Other Income/Expenses Net 0 36 0 232
Earnings Before Interest And Taxes (267) (207) (333) 167
Interest Expense – – – –
Income Before Tax (267) (207) (333) 167
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (267) (207) (333) 399
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (267) (207) (101) 167  
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (267) (207) (101) 167

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PLPL Completes $13 Million Production Facility

Plandai Biotechnology, Inc. Announces Completion of $13 Million Production Facility First Samples…

The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGODF) Is Building A World Class Organization Starting With Key Hires

The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGODF) has been executing on all…

INSYS Therapeutics, Inc. (INSY) Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray

INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray…

$EDXC Receives State Pharmacy Board Approval for its AutoSpenseTM

Endexx Receives State Pharmacy Board Approval for its AutoSpenseTM Alternative Delivery System…